Patrick Gendron - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Patrick Gendron

Showing results (41-50 of 44) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 44 results.

Nature Cancer|May 22, 2025

Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancerAnca Apavaloaei, Qingchuan Zhao, Leslie Hesnard, et al.

Cell Reports|June 5, 2024

Immunotherapeutic targeting of surfaceome heterogeneity in AMLMarie-Eve Bordeleau, Éric Audemard, Arnaud Métois, et al.

Biomarker Research|April 14, 2025

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemiaArnaud Métois, Marie-Eve Bordeleau, Louis Theret, et al.

Blood Advances|September 20, 2023

CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216Verena Gress, Mathieu Roussy, Luc Boulianne, et al.

Pageof 5

Search research articles

Showing results (41-50 of 44) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 44 results.

Nature Cancer|May 22, 2025

Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancerAnca Apavaloaei, Qingchuan Zhao, Leslie Hesnard, et al.

Cell Reports|June 5, 2024

Immunotherapeutic targeting of surfaceome heterogeneity in AMLMarie-Eve Bordeleau, Éric Audemard, Arnaud Métois, et al.

Biomarker Research|April 14, 2025

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemiaArnaud Métois, Marie-Eve Bordeleau, Louis Theret, et al.

Blood Advances|September 20, 2023

CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216Verena Gress, Mathieu Roussy, Luc Boulianne, et al.

Pageof 5